Yi-Nao-Kang Capsule ameliorates cerebral ischemia-reperfusion injury and suppresses the PERK/eIF2α/QRICH1 endoplasmic reticulum stress pathway in brain microvascular endothelial cells

Abstract Background Yi-Nao-Kang (YNK), a traditional Chinese medicine formula widely used for ischemic stroke rehabilitation, is supported by long-term clinical experience, yet the evidence for its efficacy remains limited and its neurovascular protective mechanisms are undefined, prompting this mechanistic investigation. Materials and methods We examined the mechanism by which YNK protects against cerebral ischemia–reperfusion injury (CIRI), using an in vivo middle cerebral artery occlusion (MCAO) model in SD rats and an in vitro oxygen–glucose deprivation/reoxygenation (OGD/R) model in bEnd.3 cells. The effects of YNK on the PERK/eIF2α/QRICH1 pathway were verified by Western blotting, quantitative real time PCR (qPCR), immunofluorescence staining, biochemical analysis of oxidative stress markers and detection of inflammatory cytokines. Results Compared with the MCAO model group, YNK administration reduced cerebral infarct volume, improved neurological deficits, and was accompanied by reduced endoplasmic reticulum stress (ERS), downregulated endothelial and pericyte QRICH1 expression, and mitigated oxidative stress and neuronal apoptosis; in OGD/R-exposed bEnd.3 cells, the PERK inhibitor GSK2656157 produced protective and pathway-suppressing effects similar to those of YNK. Conclusion YNK ameliorates cerebral ischemia-reperfusion injury, and its protective effects are accompanied by suppression of PERK/eIF2α/QRICH1-mediated ERS in brain microvascular endothelial cells. Because active constituents were not identified and YNK-only control groups were not included, these findings should be considered preliminary and hypothesis-generating; further preclinical evaluation is required before clinical translation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11487946/v1
Primary Topic
Endoplasmic Reticulum Stress and Disease
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Yi-Nao-Kang Capsule ameliorates cerebral ischemia-reperfusion injury and suppresses the PERK/eIF2α/QRICH1 endoplasmic reticulum stress pathway in brain microvascular endothelial cells

Ye-Feng Cai, Tian Hu, Qi-Hong Lv, Min-Hua Zheng et al.
4 links
Research Square
Endoplasmic Reticulum Stress and Disease
preprint

Yi-Nao-Kang Capsule ameliorates cerebral ischemia-reperfusion injury and suppresses the PERK/eIF2α/QRICH1 endoplasmic reticulum stress pathway in brain microvascular endothelial cells

Ye-Feng Cai, Tian Hu, Qi-Hong Lv, Min-Hua Zheng, Yu-Hui Qiu, Jian-Peng Xu, Xin Du, Xin-Yi Xu, Jie Ouyang, Shi-Jie Zhang, Jia-Yi Zheng
preprint en

Abstract

Abstract Background Yi-Nao-Kang (YNK), a traditional Chinese medicine formula widely used for ischemic stroke rehabilitation, is supported by long-term clinical experience, yet the evidence for its efficacy remains limited and its neurovascular protective mechanisms are undefined, prompting this mechanistic investigation. Materials and methods We examined the mechanism by which YNK protects against cerebral ischemia–reperfusion injury (CIRI), using an in vivo middle cerebral artery occlusion (MCAO) model in SD rats and an in vitro oxygen–glucose deprivation/reoxygenation (OGD/R) model in bEnd.3 cells. The effects of YNK on the PERK/eIF2α/QRICH1 pathway were verified by Western blotting, quantitative real time PCR (qPCR), immunofluorescence staining, biochemical analysis of oxidative stress markers and detection of inflammatory cytokines. Results Compared with the MCAO model group, YNK administration reduced cerebral infarct volume, improved neurological deficits, and was accompanied by reduced endoplasmic reticulum stress (ERS), downregulated endothelial and pericyte QRICH1 expression, and mitigated oxidative stress and neuronal apoptosis; in OGD/R-exposed bEnd.3 cells, the PERK inhibitor GSK2656157 produced protective and pathway-suppressing effects similar to those of YNK. Conclusion YNK ameliorates cerebral ischemia-reperfusion injury, and its protective effects are accompanied by suppression of PERK/eIF2α/QRICH1-mediated ERS in brain microvascular endothelial cells. Because active constituents were not identified and YNK-only control groups were not included, these findings should be considered preliminary and hypothesis-generating; further preclinical evaluation is required before clinical translation.

Research Square
Second Affiliated Hospital of Guangzhou Medical University (CN)
Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Endoplasmic Reticulum Stress and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon